Spartan II Genetic Augmentation: Difference between revisions

From Halopedia, the Halo wiki

No edit summary
(Redirected page to Project ASTER)
 
(6 intermediate revisions by 4 users not shown)
Line 1: Line 1:
==Summary==
#REDIRECT [[Project ASTER]]
In the year 2525, the [[Spartan II]]s were genetically augmented to become essentially "super humans". These procedures were extremely dangerous and for many, ended in death.
 
==Procedure Details==
===Carbide Ceramic Ossification===
*Description: Advanced material grafting onto skeletal structures to make bones virtually unbreakable. Recommended coverage not to exceed 3% total bone mass because of significant white blood cell necrosis.
*Risk(s): Specific risk for pre-and near-postpubescent adolescents: skeletal growth spurts may cause irreparable bone pulverization.
 
===Muscular Enhancement Injections===
*Description: Protein complex is injected intramuscularly to increase tissue density and decrease lactase recovery time.
*Risk(s): 5% of test subjects experience a fatal cardiac volume increase.
===Catalytic Thyroid Implant===
*Description: Platinum pellet containing human growth hormone catalyst is implanted in the thyroid to boost growth of skeletal and muscle tissues.
*Risk(s): Rare instances of elephantiasis. Suppressed sexual drive.
===Superconducting Fibrification of Neural Dendrites===
*Description: Alteration of bioeletrical nerve transduction to shielded electronic transduction. 300% increase in subject reflexes. Anecdotal evidence of marked increase in intelligence, memory, and creativity.
*Risk(s): Significant instances of Parkinson's disease and Fletcher's syndrome.
 
==Results==
After these procedures were complete, only 30 Spartans were fit for battle. Approximately a dozen were injured beyond repair and all others died. The effects were surprisingly effective; in one case 3 OSDTs were beaten to death in a accident.
 
==References==
*[[Spartan-II Training]]
*[[The Fall of Reach]]
[[Category:Technology]]
[[Category:UNSC]]

Latest revision as of 22:49, October 11, 2018

Redirect to: